Sonicated human serum albumin

Drug Profile

Sonicated human serum albumin

Alternative Names: Albunex; Infoson

Latest Information Update: 14 May 2007

Price : $50

At a glance

  • Originator Molecular Biosystems
  • Developer Mallinckrodt Medical; Molecular Biosystems; Shionogi
  • Class Albumins; Contrast media
  • Mechanism of Action Ultrasonography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No

Highest Development Phases

  • Marketed Left ventricular dysfunction

Most Recent Events

  • 26 Jan 2001 Molecular Biosystems has been acquired by Alliance Pharmaceutical Corporation
  • 01 Nov 2000 Mallinckrodt has been acquired by Tyco International
  • 10 May 1996 Registered for Left ventricular dysfunction diagnosis in Finland (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top